Skip to content
Human-limitedPeptide wrinkle relaxer targeting neuromuscular signaling

Snap-8

Also indexed as Acetyl Octapeptide-3, SNAP-8, Leuphasyl-based octapeptide, Acetyl Glutamyl Heptapeptide-1

Snap-8 is a synthetic octapeptide cosmetic active designed to reduce the appearance of expression lines and wrinkles by modulating neuromuscular signaling at the dermal-muscle interface. It is an extended analog of Argireline (Acetyl Hexapeptide-3) with two additional amino acids, offering purportedly enhanced efficacy. Originally developed for topical cosmetic application, it has also been explored in research-grade injectable formulations for more direct tissue delivery.

Overview

Topically, Snap-8 penetrates the stratum corneum via passive diffusion, aided by its relatively small molecular weight (~1075 Da) and formulation vehicle. Penetration enhancers (e.g., liposomes, nanoparticles) are commonly used to improve dermal bioavailability to peripilar and neuromuscular regions. In injectable formulations, subcutaneous or intradermal delivery bypasses the epidermal barrier, achieving higher local concentrations at target neuromuscular junctions. Plasma half-life is short due to peptidase activity; local tissue effects are expected to persist longer than systemic concentrations would suggest.

Proposed mechanism

Snap-8 mimics the N-terminal sequence of SNAP-25 (synaptosomal-associated protein 25 kDa), a component of the SNARE complex essential for vesicle docking and neurotransmitter release at the neuromuscular junction. By competing with endogenous SNAP-25 for integration into the SNARE complex, Snap-8 partially inhibits acetylcholine release, reducing muscle contraction amplitude in facial expression muscles. This leads to a relaxation of dynamic wrinkles, particularly in the forehead, periorbital, and glabellar regions.

What the evidence supports

Human data exists but the trials are small, short-term, or not yet replicated.

Graded Human-limited

Human data that exists but is thin: open-label work, single-arm studies, small cohorts, or observational follow-up without randomisation.

Key citations

Representative primary sources, including results that did not favour the compound.

  1. [1]

    Cosmetic peptides acting on the neuromuscular junction — a review of mechanisms and clinical data

    · International Journal of Cosmetic Science, 41(4), 337–341 · 2019

  2. [2]

    Snap-8 technical dossier: Acetyl Glutamyl Heptapeptide-1 for expression wrinkle reduction

    · Lipotec SAU, Barcelona, Spain (manufacturer white paper) · 2009

  3. [3]

    SNARE proteins as targets for cosmetic anti-aging actives: From bench to formulation

    · Journal of Cosmetic Dermatology, 20(8), 2382–2390 · 2021

Citation records in this build are illustrative placeholders for the design.

Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.